Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
Browsing: Pharma
2026 pharma trends demand agility from pharmacologists, drug development executives, and regulatory affairs professionals. Dive into innovations in AI-driven drug discovery, biopharma manufacturing, promising clinical pipelines, and evolving FDA regulatory trends.
BIO launches “Fight of Our Lives” campaign to commemorate 50th anniversary of industry
By healthadmin
The Biotechnology Innovation Organization (BIO) has launched a national “Fight for Our Lives” campaign, producing…
Viatris and Teva Pharmaceutical Industries recently initiated separate recalls in the United States related to…
‘Non-existent or trivial’ effects: anti-amyloid Alzheimer’s drug brought into question again
By healthadmin
Leading pharmaceutical companies have spent more than a decade researching and advancing clinical studies of…
Roche will begin a new international Phase 3 trial for its controversial Duchenne muscular dystrophy…
Lilly responds to FDA call for more safety information on Foundayo and plans parallel diabetes filing
By healthadmin
Eli Lilly is wasting no time pursuing the next indication for its newly named obesity…
Omnicom brews Olixir from FCB Health, rebrands storied agency after acquiring Interpublic
By healthadmin
Omnicom Health put its name on the recently acquired FCB Health New York, rebranding the…
The FDA’s Pharmacy Compounding Advisory Committee is scheduled to meet this summer to discuss whether…
In industry’s latest OTC strategy, Daiichi Sankyo plans to sell $1.5 billion in consumer health products to beverage giant Suntory
By healthadmin
As Daiichi Sankyo’s priorities become increasingly tied to its portfolio of innovative medicines, particularly in…
Gilead expands global Eztugo access agreement, but MSF says supply is ‘almost not enough’
By healthadmin
Despite new supply commitments from Gilead Sciences, Médecins Sans Frontières/Médecins Sans Frontières (MSF) is poking…